Summary
Abnormalities of noradrenaline metabolism and of the activity of hypothalamic-pituitary adrenal axis (HPA) have been reported in depression. To study the possible relationship between these 2 parameters, urinary excretion of 3-methoxy-4-hydroxy-phenylethyleneglycol (MHPG) and Dexamethasone Suppression Test (DST) were analyzed in 58 depressed patients. A positive correlation was found between the age of depressed patients and 24-h urinary excretion of MHPG. Twenty-two patients (38%) were DST non suppressors. Pre-DST plasma cortisol levels were significantly higher in non suppressors than suppressors. No difference was found however between urinary MHPG levels in supressors and non suppressors. There was no correlation between pre-DST plasma cortisol and levels of urinary excretion of MHPG. These results do not support the hypothesis of a relationship between these 2 parameters. However, when depressed patients were separated into two groups according to urinary excretion of MHPG (“high MHPG” and “low MHPG”), the “high MHPG” group included significantly more non suppressors then the “low MHPG” one. This result is not sufficient to demonstrate of link between HPA system activity and central noradrenaline metabolism.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, 3rd edn, DSM III. Washington, DC
Barnes RF, Veith RC, Borson S, Verhey J, Raskind MA, Halter JB (1983) High levels of plasma catecholamines in dexamethasone-resistant depressed patients. Am J Psychiatry 140: 1623–1625
Berger M, Pirke KM, Doerr P, Krieg JC, Von Zerssen D (1984) The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry. Br J Psychiatry 145: 372–382
Blomberg PA, Kopin JJ, Gordon EK, Markey SP, Ebert MH (1980) Conversion of MHPG to vanillylmandelic acid: implications for the importance of urinary MHPG. Arch Gen Psychiatry 37: 1095–1098
Carroll BJ, Curtis GC, Davies BM, Mendels J, Surgerman A (1976) Urinary free cortisol excretion in depression. Psychol Med 6: 43–50
Carroll BJ, Feinberg M, Greden JF, Tarika MA, Ariav-Albala AA, Haskett RF James NM, Kronfol Z, Lohr N, Steiner M, de Vigne JP, Young E (1981) A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatry 38: 15–22
Checkley SA (1980) Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness. Psychol Med 10: 35–53
Davis KL, Hollister LE, Mathe AA, Davis BM, Rothpearl AB, Faul KF, Hsich JYK, Barchas JD, Berger PA (1981) Neuroendocrine and neurochemical measurements in depression. Am J Psychiatry 138: 1555–1562
Ennis J, Barnes RE, Kennedy S (1985) Dexamethasone suppression test and suicidal patients. Br J Psychiatry 147: 419–423
Few D, Gawl MJ, Imms FJ (1980) The influence of the infusion of noradrenaline on plasma control levels in man. J Physiol 309: 375–389
Garver DL, Davis JM (1979) Biogenic amine hypotheses of affective disorders. Life Sci 24: 383–394
Guillaume V, Conte-Devolx B, Szafarczyk A, Pares-Herbute N, Grino M, Assenmacher I, Olivier C (1986) Inhibition of CRF release in hypophysial portal blood after 6-OHPA lesion of the ventral noradrenergic bundle. Proc 1st Int Congr Neuroendocrinology, San Francisco. Neuroendocrinology (in press)
Hollister LE, Kenneth L, Davis L, Berger PA (1980) Subtypes of depression based on excretion of MHPG and response to nortriptyline. Arch Gen Psychiatry 37: 1107–1110
Javoid JI, Rubinstein J, Davis JM (1983) Effects of pharmacological agents on MHPG. In: Maas JW (ed) MPGH: basic mechanisms and psychopathology. Academic Press, New York, pp 45–67
Jimerson DC, Insel TR, Reus VI, Kopin FJ (1983) Increased plasma MHPG in dexamethasone-resistant depressed patients. Arch Gen Psychiatry 40: 173–176
Linnoila M, Karoum F, Miller T, Potter WZ (1983) Reliability of urinary monoamine and metabolite output measurements in depressed patients. Am J Psychiatry 140: 1055–1057
Lôo H, Dennis T, Vanelle JM, Rouquier L, Poirier-Littré MF, Garreau M, Benkelfat C, Sechter D, Scatton B (1983) Lack of correlation between plasma DOPEG and urinary MOPEG levels in depressed patients. Biol Psychiatry 21: 900–906
Maas JW (ed) (1983) MHPG: basic mechanisms and psychopathology. Academic Press, New York
Maas JW, Delkirmenjian H, Dleon-Jones F (1973) The identification of depressed patients who have a disorder of norepinephrine metabolism and/or disposition. In: Usdin E, Snyder S (eds) Frontiers in catecholamines research. Pergamon Press, New York, pp 11091–11096
Maas JW, Leckman JF (1983) Relationships between central nervous system noradrenergic function and plasma and urinary MHPG and other norepinephrine metabolites. In: Maas J (ed) MHPG: basic mechanisms and psychopathology. Academic Press, New York, pp 33–34
Marantz R, Sachar EJ, Weitzman E, Sassin J (1976) Cortisol and GH responses to D and L amphetamine in monkeys. Endocrinology 99: 459–465
Pepper GM, Krieger DT (1984) Hypothalamic-pituitary-adrenal abnormalities in depression: their possible relation to central mechanisms regulating ACTH release. In: Post RM, Ballenger JC (eds) Neurobiology of mood disorders. Williams and Wilkins, Baltimore, pp 245–270
Potter WZ, Muscettola G, Goodwin FK (1983) Sources of variance in clinical studies of MHPG. In: Maas JW (ed) MHPG: basic mechanisms and psychopathology. Academic Press, New York, pp 145–165
Ridges PA (1980) The amine hypothesis in relation to the present understanding of depressive illness. Br J Clin Pract 7: 12–21
Rosenbaum AM, Maruta T, Schatzberg AF, Orsulak PJ, Jiang NS, Cole JO, Schildkraut JJ (1983) Toward a biochemical classification of depressive disorders: urinary free cortisol and urinary MHPG in depressions. Am J Psychiatry 140: 314–318
Rosenbaum AH, Schatzberg AF, Maruta T, Orsulak PJ, Cole JO, Grab EL, Schildkraut JJ (1980) MHPG as a predictor of antidepressant response to imipramine and maprotiline. Am J Psychiatry 137: 1090–1092
Roy A, Jimerson DC, Pickar D (1986) Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test. Am J Psychiatry 143: 846–851
Rubin AL, Price LH, Charney DS, Heninger GR (1985) Noradrenergic function and the cortisol response to dexamethasone in depression. Psychiatry Res 15: 5–15
Sachar EJ (1976) Neuroendocrine dysfunction in depressive illness. Ann Rev Med 27: 389–396
Sachar EJ, Asnis G, Nathan RS, Halbreich U, Trabizi MA, Halpern FS (1980) Dextroamphetamine and cortisol in depression. Arch Gen Psychiatry 37: 755–757
Scapagnini U, Van Loon GR, Moberg GP, Preziosi P, Ganong WF (1972) Evidence for a central norepinephrinergic inhibition of ACTH secretion in the rat. Neuroendocrinology 10: 155–160
Scatton B (1982) Brain 3,4-dihydroxyphenylethyleneglycol levels are dependent on central noradrenergic activity. Life Sci 31: 495–504
Schatzberg AF, Rosenbaum AH, Orsulak PJ, Rohde WA, Maruta T, Kruger AR, Cole JO, Schildkraut JJ (1981) Toward a biochemical classification of depressive disorders III: pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline. Psychopharmacology 75: 34–38
Schildkraut JJ, Orsulak PJ, Schatzberg AF, Rosenbaum AH (1983) Relationship between psychiatric diagnostic groups of depressive disorders and MHPG. In: Maas JW (ed) MHPG: basic mechanisms and psychopathology. Academic Press; New York, pp 129–144
Schlesser MA, Winokur G, Sherman BM (1980) Hypothalamic-pituitary adrenal axis activity in depressive ilness. Its relationship to classification. Arch Gen Psychiatry 37: 737–743
Sternbach HA, Extein I, Sweeney DR, Gold MS, Pottash ALC (1983) Cortisol secretion and urinary MHPG in unipolar depression. Int J Psychiatry Med 13: 261–266
Stokes PE, Frazer A, Casper R (1981) Unexpected neuroendocrine transmitter relationships. Psychopharmacol Bull 17: 72–75
Stokes PE, Stoll PM, Kaslow SH, Maas JW, Davis JM, Swann AC, Robins E (1984) Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study. Arch Gen Psychiatry 41: 257–267
Stotsky SM, Lake CR, Goodwin FK (1981) Adrenocortical function and plasma epinephrine in normal human subjects. Biol Psychiatry 16: 643–651
Szafarczyk A, Alonso G, Malaval F, Gibaud R, Assenmacher I (1986) Central adrenergic and noradrenergic stimulatory control of the CRH-ACTH axis in the rat. Proc 1st Int Congr Neuroendocrinology, San Francisco 1986, Abstract 298. Karger, Basel
Warsh JJ, Hasey G, Cooke R, Stancer HC, Persad E, Jorna T, Godse DD (1985) Elevated 3,4-dihydroxyphenylethyleneglycol (DHPG) excretion in dexamethasone resistant depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 9: 661–664
Weiner RI, Ganong WF (1978) Role of brain monoamines and histamine in regulation of anterior pituitary secretion. Physiol Rev 58: 905–976
Zhou D, Shen Y, Shu L, Lo H (1987) Dexamethasone suppression test and urinary MHPG. SO4 determination in depressive disorders. Biol Psychiatry 22: 883–891
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lôo, H., Poirier, MF., Dennis, T. et al. Lack of correlation between DST results and urinary MHPG in depressed inpatients. J. Neural Transmission 72, 121–130 (1988). https://doi.org/10.1007/BF01250235
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01250235